ecrin-mdr-crcClinical2010Gastric and Colorectal CancerGastric And Colorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2619585Japan10ECRIN MDRCompletedfalseA Clinical study to which Anti-emetic effect of change of 5-HT3RA is evaluated by using MAT in MEC for gastrointestinal cancer.Interventions: The aloxi 0.75mg is administered before the anti-cancer drug of day1 is administered. Primary outcome(s): The level of each observation point of the nausea and vomiting before and after 5- HT3RA change is evaluated by MAT. Study Design: Single arm Non-randomized2010-10-152619585JPRN-UMIN000004133